PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23704110-8	2013	CONCLUSIONS: In our sample of tissue-type plasminogen activator-treated (tPA) patients, ~1 in 5 patients developed SIRS.	Tetradecanoylphorbol Acetate	73-76	plasminogen activator, tissue type	Homo sapiens	30-64